Freehold, NJ, United States of America

William L'Amoreaux


 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovative Contributions of William L'Amoreaux

Introduction

William L'Amoreaux is a notable inventor based in Freehold, NJ (US). He has made significant contributions to the field of biomedical applications through his innovative patents. With a total of three patents to his name, L'Amoreaux continues to push the boundaries of scientific research and development.

Latest Patents

L'Amoreaux's latest patents include novel curcumin and tetrahydrocurcumin derivatives. These inventions involve modifications at one phenolic group to incorporate more-reactive groups. The derivatives are available in the form of monomers, dimers, and polymers. Another significant patent focuses on living copolymer-protein/peptide hybrids for biomedical applications. This invention features water-soluble polymers that may contain multiple immunogenicity-reducing moieties and active moieties, linked to proteins or peptides with up to twelve amino acids.

Career Highlights

William L'Amoreaux is affiliated with the City University of New York, where he contributes to research and innovation in his field. His work has garnered attention for its potential applications in medicine and biotechnology.

Collaborations

L'Amoreaux has collaborated with esteemed colleagues such as Krishnaswami Raja and Probal Banerjee. These partnerships have further enhanced the impact of his research and inventions.

Conclusion

William L'Amoreaux's innovative work in the field of biomedical applications showcases his dedication to advancing science and technology. His patents reflect a commitment to improving health outcomes through novel chemical compounds and polymers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…